| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Operating Officer | SVP, Chief Business Officer | Chief Business Officer +1 more
1 company
Korbel Gregory Alan is a SVP, Chief Operating Officer at Aprea Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 5 sells.
Estimated insider holdings value: $36K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | APRE Aprea Therapeutics, Inc. | SVP, Chief Business Officer | Sale+OE | 27,500 | $3.96 | $108,900.00 | -61.6% | -54.7% | -89.4% | |
| Nov 1, 2021 | APRE Aprea Therapeutics, Inc. | SVP, Chief Business Officer | Sale+OE | 27,500 | $5.00 | $137,500.00 | -61.6% | -58.5% | -86.7% | |
| Oct 1, 2021 | APRE Aprea Therapeutics, Inc. | SVP, Chief Business Officer | Sale+OE | 27,500 | $4.89 | $134,475.00 | -61.6% | -40.9% | -86.9% | |
| Sep 20, 2021 | APRE Aprea Therapeutics, Inc. | SVP, Chief Business Officer | Sale+OE | 32,960 | $4.97 | $163,865.80 | -49.0% | -32.8% | -84.2% | |
| Oct 7, 2019 | APRE Aprea Therapeutics, Inc. | VP Of Business Dev't | Buy | 500 | $15.00 | $7,500.00 | New | - | - |